z-logo
open-access-imgOpen Access
Effects of Angiotensin I Converting Enzyme (ACE)-Related Substances on Prostacyclin Generation and ACE Activity of Human Vascular Endothelial Cells and Rat Aortic Rings
Author(s) -
Masao Nakagawa,
S. Sawada,
Uno M,
Hajime Takamatsu,
Yuji Nakamura,
Yusuke Nakanishi,
Hajime Tsuji,
Takeo Toyoda,
Shin Sasaki,
Kazuki Takeda
Publication year - 1987
Publication title -
journal of cardiovascular pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.762
H-Index - 100
eISSN - 1533-4023
pISSN - 0160-2446
DOI - 10.1097/00005344-198706107-00022
Subject(s) - captopril , prostacyclin , bradykinin , angiotensin converting enzyme , stimulation , angiotensin ii , medicine , chemistry , contraction (grammar) , renin–angiotensin system , endocrinology , enzyme , ace inhibitor , biochemistry , receptor , blood pressure
The effects of angiotensin I (ANG I) converting enzyme (ACE)-related substances on prostacyclin (PGI2) generation were investigated using cultured human vascular endothelial cells (EC) and rat aortic rings. ANG I or bradykinin (BK) increased while captopril decreased PGI2 generation and ACE activity of EC, whereas ANG II was without effect. The enhancement of PGI2 generation induced by ANG I or BK was not affected by the pretreatment with captopril. In rat aortic rings, ANG I, ANG II, and BK enhanced whereas captopril (10(-3) M) attenuated PGI2 generation. Mechanical stimulation of aortic rings stimulated PGI2 generation. These results suggest that (a) the conversion of ANG I to ANG II did not enhance PGI2 generation in EC; (b) the ANG II stimulated PGI2 generation of aortic rings was partially derived by mechanical stimulation of EC, probably originating from the contraction of smooth muscle cells by ANG II; (c) captopril directly inhibited PGI2 generation; and (d) in EC, the stimulation of PGI2 generation by ANG I or BK is probably regulated by an activating effect on ACE as an autoregulatory mechanism.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here